About Us | Contact

Michael C Chen Investigator

Santiam Hospital NPI1619926011
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$36,098.54
from 38 payments in the last 6 years

Total Cash or Cash Equivalent

$16,760.72
from 13 payments in the last 6 years

Total In-kind Items & Services

$19,337.82
from 25 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
07/14/2021 General (Non-Research) In-kind items and services Food and Beverage $12.80 Details
Payment from GlaxoSmithKline, LLC.
Payment Record ID 802787017
02/14/2020 General (Non-Research) Cash or cash equivalent Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $25.00 Details
Payment from SANOFI-AVENTIS U.S. LLC
Payment Record ID 744143589
07/09/2020 Research In-kind items and services $368.80 Details
Payment from Eli Lilly and Company
Paymment Research Study A STUDY OF TIRZEPATIDE (LY3298176) ONCE A WEEK VERSUS INSULIN GLARGINE ONCE A DAY IN PARTICIPANTS WITH TYPE 2 DIABETES AND INCREASED CARDIOVASCULAR RISK
Clinical Trials Gov ID NCT03730662
Payment Record ID 728725707
07/09/2020 Research In-kind items and services $276.50 Details
Payment from Eli Lilly and Company
Paymment Research Study A RANDOMIZED, PHASE 3, OPEN-LABEL TRIAL COMPARING THE EFFECT OF LY3298176 VERSUS TITRATED INSULIN DEGLUDEC ON GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES
Clinical Trials Gov ID NCT03882970
Payment Record ID 728722857
08/16/2019 General (Non-Research) In-kind items and services Food and Beverage $11.83 Details
Payment from Circassia Pharmaceuticals Inc
Payment Record ID 660212163
01/08/2019 Research Cash or cash equivalent Drug $6536.00 Details
Payment from Eli Lilly and Company
Paymment Research Study A RANDOMIZED, DOUBLE-BLIND, PARALLEL ARM STUDY OF THE EFFICACY AND SAFETY OF INVESTIGATIONAL DULAGLUTIDE DOSES WHEN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Clinical Trials Gov ID NCT03495102
Payment Record ID 654283847
01/16/2019 Research In-kind items and services $75.60 Details
Payment from Eli Lilly and Company
Paymment Research Study A STUDY OF LY3209590 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS
Clinical Trials Gov ID NCT03736785
Payment Record ID 654283601
01/07/2019 Research Cash or cash equivalent $7193.00 Details
Payment from Eli Lilly and Company
Paymment Research Study A STUDY OF LY3209590 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS
Clinical Trials Gov ID NCT03736785
Payment Record ID 654283037
12/24/2018 Research Cash or cash equivalent Drug $1500.00 Details
Payment from Eli Lilly and Company
Paymment Research Study A RANDOMIZED, DOUBLE-BLIND, PARALLEL ARM STUDY OF THE EFFICACY AND SAFETY OF INVESTIGATIONAL DULAGLUTIDE DOSES WHEN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Clinical Trials Gov ID NCT03495102
Payment Record ID 585604135
03/15/2018 Research In-kind items and services Drug $2990.94 Details
Payment from Eli Lilly and Company
Paymment Research Study A RANDOMIZED, DOUBLE-BLIND, PARALLEL ARM STUDY OF THE EFFICACY AND SAFETY OF INVESTIGATIONAL DULAGLUTIDE DOSES WHEN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Clinical Trials Gov ID NCT03495102
Payment Record ID 585604133
12/28/2018 Research Cash or cash equivalent $1050.00 Details
Payment from Eli Lilly and Company
Paymment Research Study A STUDY OF LY3209590 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS
Clinical Trials Gov ID NCT03736785
Payment Record ID 585604131
03/09/2018 General (Non-Research) In-kind items and services Travel and Lodging $277.57 Details
Payment from Eli Lilly and Company
Payment Record ID 559568535
03/09/2018 General (Non-Research) In-kind items and services Travel and Lodging $225.00 Details
Payment from Eli Lilly and Company
Payment Record ID 559568531
03/09/2018 General (Non-Research) In-kind items and services Food and Beverage $325.91 Details
Payment from Eli Lilly and Company
Payment Record ID 559568527
12/03/2018 General (Non-Research) Cash or cash equivalent Travel and Lodging $20.00 Details
Payment from Eli Lilly and Company
Payment Record ID 559568523
11/19/2018 General (Non-Research) Cash or cash equivalent Travel and Lodging $109.00 Details
Payment from Eli Lilly and Company
Payment Record ID 559568519
10/24/2018 General (Non-Research) In-kind items and services Travel and Lodging $194.86 Details
Payment from Eli Lilly and Company
Payment Record ID 559568515
11/19/2018 General (Non-Research) Cash or cash equivalent Food and Beverage $12.33 Details
Payment from Eli Lilly and Company
Payment Record ID 559568511
10/26/2018 General (Non-Research) In-kind items and services Travel and Lodging $229.37 Details
Payment from Eli Lilly and Company
Payment Record ID 559568507
10/26/2018 General (Non-Research) In-kind items and services Travel and Lodging $290.60 Details
Payment from Eli Lilly and Company
Payment Record ID 559568503
10/26/2018 General (Non-Research) In-kind items and services Food and Beverage $287.21 Details
Payment from Eli Lilly and Company
Payment Record ID 559568499
10/25/2018 General (Non-Research) In-kind items and services Travel and Lodging $444.40 Details
Payment from Eli Lilly and Company
Payment Record ID 559568495
04/09/2018 General (Non-Research) Cash or cash equivalent Food and Beverage $114.52 Details
Payment from Eli Lilly and Company
Payment Record ID 559568493
02/15/2017 Research In-kind items and services Drug $202.88 Details
Payment from Eli Lilly and Company
Paymment Research Study A PHASE 2, DOUBLE-BLIND, PLACEBO-CONTROLLED, 18-WEEK TRIAL OF INVESTIGATIONAL DULAGLUTIDE DOSES VERSUS PLACEBO IN PATIENTS WITH TYPE 2 DIABETES ON METFORMIN MONOTHERAPY
Clinical Trials Gov ID NCT02973100
Payment Record ID 457098045
05/25/2017 Research In-kind items and services $8423.94 Details
Payment from Eli Lilly and Company
Paymment Research Study A PHASE 2 STUDY OF ONCE-WEEKLY LY3298176 COMPARED WITH PLACEBO AND DULAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Clinical Trials Gov ID NCT03131687
Payment Record ID 457098043
02/15/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $75.00 Details
Payment from Roche Diagnostics Corporation
Payment Record ID 402459902
01/06/2016 General (Non-Research) Cash or cash equivalent Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $35.00 Details
Payment from SANOFI-AVENTIS U.S. LLC
Payment Record ID 394794038
01/22/2016 General (Non-Research) In-kind items and services Travel and Lodging $380.30 Details
Payment from Novo Nordisk AS
Payment Record ID 391733694
01/22/2016 General (Non-Research) In-kind items and services Travel and Lodging $260.08 Details
Payment from Novo Nordisk AS
Payment Record ID 391733684
01/22/2016 General (Non-Research) In-kind items and services Food and Beverage $552.89 Details
Payment from Novo Nordisk AS
Payment Record ID 391733674
01/22/2016 General (Non-Research) In-kind items and services Travel and Lodging $379.70 Details
Payment from Novo Nordisk AS
Payment Record ID 391733666
10/28/2016 General (Non-Research) In-kind items and services Travel and Lodging $258.24 Details
Payment from Eli Lilly and Company
Payment Record ID 378185764
10/28/2016 General (Non-Research) In-kind items and services Travel and Lodging $232.00 Details
Payment from Eli Lilly and Company
Payment Record ID 378185734
10/28/2016 General (Non-Research) In-kind items and services Food and Beverage $190.00 Details
Payment from Eli Lilly and Company
Payment Record ID 378185712
11/21/2016 General (Non-Research) Cash or cash equivalent Travel and Lodging $78.88 Details
Payment from Eli Lilly and Company
Payment Record ID 378185684
10/25/2016 General (Non-Research) In-kind items and services Travel and Lodging $263.74 Details
Payment from Eli Lilly and Company
Payment Record ID 378185664
11/21/2016 General (Non-Research) Cash or cash equivalent Food and Beverage $11.99 Details
Payment from Eli Lilly and Company
Payment Record ID 378185628
11/16/2016 Research In-kind items and services Drug $2182.66 Details
Payment from Eli Lilly and Company
Paymment Research Study A PHASE 2, DOUBLE-BLIND, PLACEBO-CONTROLLED, 18-WEEK TRIAL OF INVESTIGATIONAL DULAGLUTIDE DOSES VERSUS PLACEBO IN PATIENTS WITH TYPE 2 DIABETES ON METFORMIN MONOTHERAPY
Clinical Trials Gov ID NCT02973100
Payment Record ID 372522188
;